RBS Royal Bank of Scotland Group PLC

By Tapan Panchal

LONDON--GlaxoSmithKline PLC (GSK.LN) confirmed on Thursday that Philip Hampton, the current chairman of Royal Bank of Scotland Group PLC (RBS.LN), will become the chairman of the pharmaceutical company on May 7.

Mr. Hampton was named as the new chairman in September. He will replace Christopher Gent, who will step down at the annual general meeting on May 7. Mr. Hampton will first become deputy chairman on April 1 and then take over as chairman at the end of the annual meeting.

Mr. Hampton will remain chairman of Royal Bank of Scotland until Aug. 31, Glaxo said.

Write to Tapan Panchal at tapan.panchal@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires